Stock Market Marksans Pharma shares jump 2% following USFDA approval for Loratadine Tablets USP… Aman Shukla Nov 22, 2024
Corporates Marksans Pharma receives USFDA approval for Loratadine Tablets USP 10 mg Aditya Bhagchandani Nov 22, 2024
Corporates Marksans Pharma Q2 FY25: Revenue up 20.84% YoY to Rs 641.92 crore, Net Profit up… Aditya Bhagchandani Nov 12, 2024
Stock Market Marksans Pharma Q2 FY25 results: Stock surge over 3% ahead of result announcement Aman Shukla Nov 12, 2024
